Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk

2025/04/09 by Chenxi Ouyang, Liang Zhou, Jiahao Liu +2 · 2 citations
Medicine · #Chronic Kidney Disease and Diabetes #Cohort #Confidence interval #Hazard ratio #Hyperplasia #Incidence (geometry) #Internal medicine #Kidney disease #Medicine #Proportional hazards model #Prospective cohort study #Prostate Cancer Diagnosis and Treatment #Renal function #Urinary Bladder and Prostate Research #Urology

paper · doi:10.1016/j.mayocp.2024.11.024

openalex publication_date 2025/04/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors

Cited by

• SGLT2 Inhibitors in Patients with Urogenital Malformations and Urinary Diversions: Risks, Benefits, and Clinical Considerations. [europepmc]
• Disease Progression and Outcomes in Patients With Benign Prostatic Hyperplasia: Protocol for a Multicenter Retrospective Cohort Study. [europepmc]